Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons.
作者信息
Tangpricha Vin
机构信息
Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
The Atlanta VA Medical Center, Decatur, GA, USA.
出版信息
J Clin Endocrinol Metab. 2022 May 17;107(6):e2632-e2633. doi: 10.1210/clinem/dgac060.
Abstract
摘要
相似文献
1
Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons.性别肯定激素疗法与跨性别者患糖尿病的风险
J Clin Endocrinol Metab. 2022 May 17;107(6):e2632-e2633. doi: 10.1210/clinem/dgac060.
2
SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.接受性别肯定激素治疗的跨性别个体的血清激素浓度：一项纵向回顾性队列研究。
Endocr Pract. 2021 Jan;27(1):27-33. doi: 10.4158/EP-2020-0414. Epub 2020 Nov 18.
3
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.澳大利亚跨性别和性别多样化成年人的性别肯定激素治疗。
Intern Med J. 2024 Sep;54(9):1450-1457. doi: 10.1111/imj.16413. Epub 2024 Jul 26.
4
Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate.接受每日恩曲他滨/替诺福韦二吡呋酯治疗的青少年和年轻成年跨性别者的性别肯定激素药代动力学。
AIDS Res Hum Retroviruses. 2022 Dec;38(12):939-943. doi: 10.1089/AID.2022.0044. Epub 2022 Aug 9.
5
Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.自我开具性别确认激素疗法的跨性别女性体内激素浓度：一项回顾性研究。
J Sex Med. 2022 May;19(5):864-871. doi: 10.1016/j.jsxm.2022.02.023. Epub 2022 Apr 1.
6
Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.跨性别成年人的性别肯定激素治疗、血管健康和心血管疾病。
Hypertension. 2019 Dec;74(6):1266-1274. doi: 10.1161/HYPERTENSIONAHA.119.13080. Epub 2019 Oct 28.
7
Risk assessment of transgender people: implementation of a demasculinizing-feminizing rodent model including the evaluation of thyroid homeostasis.跨性别者风险评估：去势-女性化啮齿动物模型的实施，包括甲状腺内稳态的评估。
Biol Direct. 2024 Jan 2;19(1):5. doi: 10.1186/s13062-023-00450-1.
8
Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.丹麦跨性别者的性别肯定激素治疗：一项全国范围内基于登记的研究。
Andrology. 2022 Jul;10(5):885-893. doi: 10.1111/andr.13181. Epub 2022 Apr 18.
9
New Data to Challenge Gender-affirming Hormone Therapy Prescribing Practice.新数据挑战性别确认激素治疗的处方实践。
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2365-e2366. doi: 10.1210/clinem/dgab006.
10
Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.跨性别退伍军人的性别肯定激素治疗与代谢综合征。
JAMA Netw Open. 2024 Jul 1;7(7):e2419696. doi: 10.1001/jamanetworkopen.2024.19696.
引用本文的文献
1
Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy.性别肯定激素治疗后跨性别者的心血管危险因素
J Clin Med. 2023 Sep 23;12(19):6141. doi: 10.3390/jcm12196141.
2
Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment.葡萄糖稳态、糖尿病与性别肯定治疗。
Biomedicines. 2023 Feb 22;11(3):670. doi: 10.3390/biomedicines11030670.
本文引用的文献
1
Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy.使用激素治疗的跨性别者发生糖尿病的风险并未增加。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2000-e2007. doi: 10.1210/clinem/dgab934.
2
Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data From the STRONG Cohort.激素使用与跨性别者糖尿病发病率之间是否存在关联？来自 STRONG 队列的数据。
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1549-e1557. doi: 10.1210/clinem/dgab832.
3
Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria.接受激素治疗的成年跨性别者五十年间的死亡率趋势：来自阿姆斯特丹性别焦虑症队列的报告。
Lancet Diabetes Endocrinol. 2021 Oct;9(10):663-670. doi: 10.1016/S2213-8587(21)00185-6. Epub 2021 Sep 2.
4
Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.评估和改善跨性别者和性别多样化者的心血管健康：美国心脏协会的科学声明。
Circulation. 2021 Aug 10;144(6):e136-e148. doi: 10.1161/CIR.0000000000001003. Epub 2021 Jul 8.
5
Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.性别肯定激素疗法对跨性别者体重指数的影响：一项纵向队列研究。
J Clin Transl Endocrinol. 2020 Jul 3;21:100230. doi: 10.1016/j.jcte.2020.100230. eCollection 2020 Sep.
6
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.跨性别者的性激素与急性心血管事件：一项队列研究。
Ann Intern Med. 2018 Aug 21;169(4):205-213. doi: 10.7326/M17-2785. Epub 2018 Jul 10.
7
Effects of Sex Hormone Treatment on the Metabolic Syndrome in Transgender Individuals: Focus on Metabolic Cytokines.性别激素治疗对跨性别个体代谢综合征的影响：聚焦代谢细胞因子。
J Clin Endocrinol Metab. 2018 Feb 1;103(2):790-802. doi: 10.1210/jc.2017-01559.
8
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.性别焦虑/性别不一致者的内分泌治疗：内分泌学会临床实践指南
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903. doi: 10.1210/jc.2017-01658.
Zotero 插件